New Milford, NJ, United States of America

Marcela Torres




Average Co-Inventor Count = 13.0

ph-index = 4

Forward Citations = 191(Granted Patents)


Location History:

  • New Milford, NJ (US) (2009 - 2012)
  • Congers, NY (US) (2012)

Company Filing History:


Years Active: 2009-2012

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Marcela Torres and Her Contributions to Antibody Therapy

Introduction: Marcela Torres, an accomplished inventor based in New Milford, NJ, exemplifies the spirit of innovation in the field of biotechnology. With four patents to her name, she is recognized for her significant contributions to the development of high-affinity human antibodies. Her work holds promise for a variety of therapeutic applications, particularly in treating diseases linked to interleukin-4 activity.

Latest Patents: Among her latest patents, Torres has developed a high-affinity human antibody that targets the human interleukin-4 receptor alpha (hIL-4Rα) with an affinity constant of less than 200 pM, as determined by surface plasmon resonance. Furthermore, her methodologies provide effective treatment options for diseases or disorders associated with enhanced IL-4 activity. These innovations pave the way for potential therapies that could improve the quality of life for patients affected by such conditions.

Career Highlights: Marcela Torres's career is marked by her role at Regeneron Pharmaceuticals, Inc., where she plays a pivotal part in groundbreaking projects aimed at understanding and manipulating immune responses. Her expertise in antibody development has positioned her as a leading figure in her field.

Collaborations: Throughout her career, she has collaborated with other notable scientists, including her coworkers Sean Stevens and Tammy T Huang. These partnerships have fostered a creative environment that enhances research and innovation in therapeutic antibody development.

Conclusion: Marcela Torres's work represents a significant advancement in the biotechnology sector, particularly in the realm of antibody therapies for diseases influenced by interleukin-4. With her continued dedication to research and innovation, Torres is sure to leave a lasting impact on the healthcare industry and improve patient outcomes through her inventive solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…